TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ: 200230)

TELCON RF PHARMACEUTICAL. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,707	8,519	9,734	23,195	24,542	15,728
Short-Term Investments	1,200	2,000	-	-	188.64	160
Cash & Short-Term Investments	6,907	10,519	9,734	23,195	24,730	15,888
Cash Growth	-58.53%	8.07%	-58.04%	-6.21%	55.66%	115.67%
Accounts Receivable	3,391	8,991	6,139	9,479	8,550	11,930
Other Receivables	311.4	177.97	267.88	224.23	2,214	423.96
Receivables	3,760	16,222	6,439	9,703	10,764	12,380
Inventory	4,917	5,003	4,622	4,303	4,276	4,189
Prepaid Expenses	78.4	83.2	73.74	98.87	105.63	122.22
Other Current Assets	3,112	1,161	2,258	55.98	280.83	14.04
Total Current Assets	18,773	32,989	23,127	37,357	40,158	32,593
Property, Plant & Equipment	11,092	8,468	8,038	9,320	8,417	7,107
Long-Term Investments	95,336	74,800	63,375	90,287	103,415	53,245
Goodwill	-	-	-	-	-	4,179
Other Intangible Assets	20,062	21,338	23,881	30,201	32,153	31,285
Long-Term Accounts Receivable	-	-	-	-0	-0	0
Other Long-Term Assets	2,757	2,774	799.52	864.83	909.05	1,077
Total Assets	148,071	140,415	119,255	168,030	185,053	129,487
Accounts Payable	2,585	2,581	2,668	2,630	2,639	2,352
Accrued Expenses	1,120	697.9	720.39	901.94	1,108	635.64
Short-Term Debt	39,147	26,443	28,853	53,991	84,883	9,659
Current Portion of Long-Term Debt	0	0	0	0	240	240
Current Portion of Leases	534.31	577.16	694.1	644.11	618.92	514.86
Other Current Liabilities	11,852	4,625	1,394	1,946	1,433	1,201
Total Current Liabilities	55,238	34,924	34,329	60,113	90,921	14,603
Long-Term Debt	-	-	-	-	900	1,140
Long-Term Leases	264.23	403.02	727.85	1,301	1,674	617.58
Other Long-Term Liabilities	146.25	143.41	62.77	7.91	81.39	1.17
Total Liabilities	55,649	35,470	35,120	61,422	93,577	16,362
Common Stock	12,025	11,599	10,860	9,991	8,751	8,528
Additional Paid-In Capital	245,985	243,907	238,108	216,003	180,991	164,327
Retained Earnings	-171,283	-154,142	-168,048	-126,310	-103,212	-62,319
Comprensive Income & Other	5,393	3,094	3,203	6,896	4,809	1,319
Total Common Equity	92,121	104,459	84,123	106,580	91,339	111,855
Minority Interest	301.6	485.46	12.26	27.59	136.38	1,270
Shareholders' Equity	92,422	104,945	84,135	106,608	91,475	113,125
Total Liabilities & Equity	148,071	140,415	119,255	168,030	185,053	129,487
Total Debt	39,946	27,423	30,275	55,936	88,316	12,172
Net Cash (Debt)	-33,039	-16,904	-20,542	-32,741	-63,586	3,716
Net Cash Per Share	-288.42	-113.04	-149.58	-372.70	-742.95	44.85
Filing Date Shares Outstanding	120.25	115.99	108.6	99.91	87.51	85.28
Total Common Shares Outstanding	120.25	115.99	108.6	99.91	87.51	85.28
Working Capital	-36,465	-1,935	-11,202	-22,756	-50,764	17,990
Book Value Per Share	766.07	900.55	774.58	1066.77	1043.77	1311.66
Tangible Book Value	72,059	83,121	60,242	76,379	59,186	76,390
Tangible Book Value Per Share	599.24	716.59	554.69	764.49	676.34	895.79
Land	827.37	827.37	827.37	827.37	827.37	863.37
Buildings	5,319	5,082	4,974	4,867	3,508	3,498
Machinery	8,552	7,700	8,016	7,927	8,165	8,597
Construction In Progress	3,003	-	325	316	233.8	157.5

Source: S&P Capital IQ. Standard template. Financial Sources.